| Trial ID: | L0583 |
| Source ID: | IRCT2016040727265N1
|
| Associated Drug: |
Ursobil
|
| Title: |
Comparison of the effect of Ursobil and Silymarine in non alchoholic fatty liver
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic steatohepatitis. <br>nonalcoholic steatohepatitis;nonalcoholic steatohepatitis
|
| Interventions: |
Intervention 1: First group will be received Ursobil (oral capsule; 300mg BD for 4 weeks). Intervention 2: Second group will be received Silymarin (oral tablet ; 140 mg BD for 4 weeks).;Treatment - Drugs;Treatment - Drugs;First group will be received Ur
|
| Outcome Measures: |
Liver enzymes. Timepoint: Before intervention and 4 weeks after intervention. Method of measurement: By laboratory analysis ( blood test).;Serum insulin. Timepoint: Before intervention and 4 weeks after intervention. Method of measurement: Chemiluminescence.;Fasting blood sugar. Timepoint: Before intervention and 4 weeks after intervention. Method of measurement: By laboratory analysis ( blood test).;Lipid profile. Timepoint: Before intervention and 4 weeks after intervention. Method of measurement: By laboratory analysis ( blood test).;Inflammatory marker. Timepoint: Before intervention and 4 weeks after intervention. Method of measurement: By laboratory analysis ( blood test).nan
|
| Sponsor/Collaborators: |
Vice Chancellor for research Qazvin University of Medical Sciences
|
| Gender: |
All
|
| Age: |
no limitno limit
|
| Phases: |
Phase 3
|
| Enrollment: |
70
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.
|
| Start Date: |
29/05/2016
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of);Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/22380
|
